FI63035C - Foerfarande foer framstaellning av 7-alfa-aminoacyl-3-klorcefalosporinderivat - Google Patents

Foerfarande foer framstaellning av 7-alfa-aminoacyl-3-klorcefalosporinderivat Download PDF

Info

Publication number
FI63035C
FI63035C FI525/74A FI52574A FI63035C FI 63035 C FI63035 C FI 63035C FI 525/74 A FI525/74 A FI 525/74A FI 52574 A FI52574 A FI 52574A FI 63035 C FI63035 C FI 63035C
Authority
FI
Finland
Prior art keywords
carboxylic acid
chloro
cephem
amino
ester
Prior art date
Application number
FI525/74A
Other languages
English (en)
Finnish (fi)
Other versions
FI63035B (fi
Inventor
Robert Raymond Chauvette
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to FI793178A priority Critical patent/FI793178A/fi
Publication of FI63035B publication Critical patent/FI63035B/fi
Application granted granted Critical
Publication of FI63035C publication Critical patent/FI63035C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI525/74A 1973-02-23 1974-02-22 Foerfarande foer framstaellning av 7-alfa-aminoacyl-3-klorcefalosporinderivat FI63035C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI793178A FI793178A (fi) 1973-02-23 1979-10-12 3-klor-7-alfa-aminoacylcefalosporinderivat vilka aer anvaendbara saosom mellanprodukter vid framstaellning av oralt verksamma 3-klor-substituerade cefalosporinantibiotika

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33538173A 1973-02-23 1973-02-23
US33538173 1973-02-23

Publications (2)

Publication Number Publication Date
FI63035B FI63035B (fi) 1982-12-31
FI63035C true FI63035C (fi) 1983-04-11

Family

ID=23311540

Family Applications (1)

Application Number Title Priority Date Filing Date
FI525/74A FI63035C (fi) 1973-02-23 1974-02-22 Foerfarande foer framstaellning av 7-alfa-aminoacyl-3-klorcefalosporinderivat

Country Status (37)

Country Link
JP (4) JPS6139313B2 (da)
AR (1) AR199510A1 (da)
AT (1) AT333953B (da)
BE (1) BE811495A (da)
BR (1) BR7401384D0 (da)
CA (1) CA1016537A (da)
CH (1) CH593988A5 (da)
CS (1) CS187409B2 (da)
CY (1) CY1043A (da)
DD (1) DD110278A5 (da)
DE (1) DE2408698C2 (da)
DK (1) DK153157C (da)
EG (1) EG11104A (da)
ES (1) ES423531A1 (da)
FI (1) FI63035C (da)
FR (1) FR2218877B1 (da)
GB (1) GB1461323A (da)
GT (1) GT197432133A (da)
HK (1) HK20080A (da)
HU (1) HU166849B (da)
IE (1) IE39046B1 (da)
IL (1) IL44262A (da)
IN (1) IN139620B (da)
KE (1) KE3027A (da)
MW (1) MW674A1 (da)
MY (1) MY8100024A (da)
NL (1) NL179057C (da)
NO (2) NO148375C (da)
OA (1) OA04809A (da)
PH (1) PH9616A (da)
PL (1) PL88702B1 (da)
RO (1) RO64663A (da)
SE (1) SE411212B (da)
SU (1) SU676166A3 (da)
YU (1) YU36970B (da)
ZA (1) ZA741191B (da)
ZM (1) ZM3574A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342197B (de) * 1975-02-20 1978-03-28 Ciba Geigy Ag Neues verfahren zur herstellung von 3-cephemverbindungen
CH619233A5 (da) * 1975-07-31 1980-09-15 Ciba Geigy Ag
CH622802A5 (da) * 1975-08-20 1981-04-30 Ciba Geigy Ag
IE45158B1 (en) * 1976-08-16 1982-06-30 Lilly Co Eli 3-chloro-cephem synthesis
DE3508258A1 (de) * 1985-03-08 1986-09-18 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
DE3509618A1 (de) 1985-03-16 1986-09-18 Bayer Ag, 5090 Leverkusen Ss-lactam-antibiotika, verfahren zur herstellung und ihre verwendung als arzneimittel
JPS6436445U (da) * 1987-08-28 1989-03-06
DE3803169A1 (de) 1988-02-03 1989-08-17 Bayer Ag Ss-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln
ES2010075A6 (es) * 1989-01-10 1989-10-16 Antibioticos Sa Un procedimiento para la preparacion de compuestos de 3-cloro-cefem.
JP2539459Y2 (ja) * 1991-12-18 1997-06-25 三重ホーロー株式会社 組立式塵芥焼却器
IT1255458B (it) * 1992-05-11 1995-11-02 Col Marco Da Procedimento per la preparazione di derivati beta-lattamici alogenati
ES2079327B1 (es) 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
CN101805357B (zh) * 2010-04-28 2012-01-11 陶灵刚 一种头孢克洛化合物及其制法
CN103588790A (zh) * 2013-11-29 2014-02-19 中国科学院长春应用化学研究所 7-氨基-3-氯-3-头孢-4-羧酸-对硝基苄基酯的制备方法
CN106632400A (zh) * 2016-12-16 2017-05-10 石家庄柏奇化工有限公司 Pd‑C催化氢化脱除4‑硝基苄基制备7‑ACCA的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
DE2265798C2 (de) * 1971-06-24 1985-09-26 Fujisawa Pharmaceutical Co., Ltd., Osaka Verfahren zur Herstellung von Oxoazetidin-Derivaten
AR206201A1 (es) * 1972-06-29 1976-07-07 Ciba Geigy Ag Procedimiento para la obtencion de compuestos de acido 7beta-amino-3-cefem-3-01-4-carboxilico0-substituidos

Also Published As

Publication number Publication date
NO148377B (no) 1983-06-20
JPS6140237B2 (da) 1986-09-08
CA1016537A (en) 1977-08-30
AT333953B (de) 1976-12-27
PH9616A (en) 1976-01-20
FI63035B (fi) 1982-12-31
CS187409B2 (en) 1979-01-31
NO148377C (no) 1983-09-28
JPS6140235B2 (da) 1986-09-08
YU36970B (en) 1984-08-31
IN139620B (da) 1976-07-10
EG11104A (en) 1976-12-31
PL88702B1 (da) 1976-09-30
SU676166A3 (ru) 1979-07-25
DE2408698A1 (de) 1974-09-05
IL44262A0 (en) 1974-05-16
JPS56138190A (en) 1981-10-28
CY1043A (en) 1980-08-01
CH593988A5 (da) 1977-12-30
IE39046B1 (en) 1978-07-19
FR2218877B1 (da) 1977-03-11
JPS56138192A (en) 1981-10-28
ATA142574A (de) 1976-04-15
JPS56138191A (en) 1981-10-28
JPS6139313B2 (da) 1986-09-03
OA04809A (fr) 1980-08-31
IE39046L (en) 1974-08-23
JPS49110689A (da) 1974-10-22
AU6591674A (en) 1975-08-28
NO148375C (no) 1983-09-28
AR199510A1 (es) 1974-09-09
MY8100024A (en) 1981-12-31
NL179057B (nl) 1986-02-03
NO740606L (no) 1974-08-26
RO64663A (fr) 1979-02-15
HU166849B (da) 1975-06-28
DK153157C (da) 1988-10-31
FR2218877A1 (da) 1974-09-20
ZA741191B (en) 1975-10-29
KE3027A (en) 1980-03-14
MW674A1 (en) 1975-04-09
DK153157B (da) 1988-06-20
ZM3574A1 (en) 1975-11-21
DE2408698C2 (de) 1983-11-10
NO792681L (no) 1974-08-26
ES423531A1 (es) 1976-05-16
HK20080A (en) 1980-04-25
JPS6140236B2 (da) 1986-09-08
GT197432133A (es) 1975-08-16
GB1461323A (en) 1977-01-13
NL179057C (nl) 1986-07-01
NO148375B (no) 1983-06-20
SE411212B (sv) 1979-12-10
IL44262A (en) 1977-08-31
YU39974A (en) 1982-06-18
BE811495A (fr) 1974-08-22
NL7402489A (da) 1974-08-27
BR7401384D0 (pt) 1974-11-05
DD110278A5 (da) 1974-12-12

Similar Documents

Publication Publication Date Title
US3925372A (en) Alpha-aminoacyl-3-halo cephalosporins
FI63035C (fi) Foerfarande foer framstaellning av 7-alfa-aminoacyl-3-klorcefalosporinderivat
US3962227A (en) 3-halo cephalosporins
US4064343A (en) 3-Halo cephalosporins
US3917588A (en) {60 -Aminoacyl cephalosporin ethers
IE43845B1 (en) 4-thia-1-azabicyclo/4.2.0/oct-2-ene derivatives
FI63240C (fi) Analogifoerfarande foer framstaellning av antibakteriella 3-klorcefalosporinderivat
KR870000528B1 (ko) 3-아지도 세팔로스포린의 제조방법
US4208515A (en) 3-Halo cephalosporins
US4103086A (en) 8-Oxo-4-thia-1-azabicyclo (4.2.0)-oct-2-ene derivatives
US4501741A (en) Cephalosporin antibiotics
US3941779A (en) Method for producing 2-(substituted thio)-3-cephem derivatives
US3985737A (en) 3-Sulfonate esters of cephalosporin
US4252950A (en) 3-Halo cephalosporins
US4281116A (en) 3-Halo cephalosporins
Applegate et al. DIASTEREOMERIC 7-UREIDOACETYL CEPHALOSPORINS. II 7β-[[[(AMINOCARBONYL) AMINO]-2-THIENYLACETYL] AMINO]-7-METHOXY-3-[[(1-METHYL-1H-TETRAZOL-5-YL) THIO] METHYL]-8-OXO-5-THIA-1-AZABICYCLO [4.2. 0] OCT-2-ENE-2-CARBOXYLIC ACID
US4260745A (en) 3-Halo cephalosporins
EP0122154A2 (en) Improvements in or relating to benzothienylglycyl cephalosporin derivatives
US4490370A (en) Naphthylglycyl cephalosporin derivatives
GB2137997A (en) Improvements in or relating to indolylglycyl cephalosporin derivatives
US4304774A (en) Bis-tetrazolmethyl substituted β-lactam antibiotics
US3971776A (en) Thio-β-lactam penicillins
EP0188781B1 (en) 1-oxa-1-dethia-cephalosporin compounds and antibacterial agent comprising the same
US4497811A (en) 1-Oxadethiacephalosporin compound and antibacterial agent containing the _same
GB2137993A (en) Improvements in or relating to naphthylglycyl cephalosporin derivatives